Salem Investment Counselors Inc. purchased a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 66,530 shares of the biotechnology company’s stock, valued at approximately $1,238,000. Salem Investment Counselors Inc. owned approximately […]
Deerfield Management Company L.P. Series C lifted its position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) by 13.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,279,000 shares of the biotechnology company’s stock after purchasing an additional 154,000 shares during the quarter. Deerfield […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) had its price target increased by investment analysts at HC Wainwright from $33.00 to $90.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s price target indicates a potential upside of 32.63% from the […]
Aigen Investment Management LP acquired a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 13,396 shares of the biotechnology company’s stock, valued at approximately $148,000. Several other institutional investors and […]
Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 310,000 shares of the biotechnology company’s stock, valued at approximately $3,432,000. Healthcare of […]